Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/16/2026 | 4,202 | 0.1% | 63,300 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 2,194 | 0.0% | 63,600 | 9/30/2025 |
| 2025 Q2 | 7/23/2025 | 927 | 0.0% | 58,700 | 6/30/2025 |
| 2025 Q1 | 5/1/2025 | 757 | 0.0% | 59,400 | 3/31/2025 |
| 2024 Q4 | 1/29/2025 | 649 | 0.0% | 34,500 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 668 | 0.0% | 34,500 | 9/30/2024 |
| 2024 Q2 | 7/24/2024 | 912 | 0.0% | 35,100 | 6/30/2024 |
| 2024 Q1 | 4/23/2024 | 1,021 | 0.0% | 35,700 | 3/31/2024 |
| 2023 Q4 | 1/29/2024 | 921 | 0.0% | 30,100 | 12/31/2023 |
| 2023 Q3 | 10/17/2023 | 817 | 0.0% | 30,400 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 1,113 | 0.0% | 31,200 | 6/30/2023 |
| 2023 Q1 | 4/19/2023 | 729 | 0.0% | 28,700 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 1,148 | 0.0% | 28,300 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 932 | 0.0% | 28,200 | 9/30/2022 |
| 2022 Q2 | 7/20/2022 | 1,186 | 0.0% | 27,800 | 6/30/2022 |
| 2022 Q1 | 4/22/2022 | 1,263 | 0.0% | 27,600 | 3/31/2022 |
| 2021 Q4 | 1/14/2022 | 1,777 | 0.0% | 26,800 | 12/31/2021 |
| 2021 Q3 | 10/12/2021 | 1,661 | 0.0% | 26,600 | 9/30/2021 |
| 2021 Q2 | 7/16/2021 | 2,236 | 0.1% | 27,000 | 6/30/2021 |
| 2021 Q1 | 4/14/2021 | 1,790 | 0.0% | 27,000 | 3/31/2021 |
| 2020 Q4 | 1/11/2021 | 1,972 | 0.1% | 25,700 | 12/31/2020 |
| 2020 Q3 | 10/19/2020 | 1,098 | 0.1% | 25,500 | 9/30/2020 |
| 2020 Q2 | 7/13/2020 | 1,097 | 0.1% | 25,400 | 6/30/2020 |
| 2020 Q1 | 4/13/2020 | 696 | 0.1% | 24,200 | 3/31/2020 |
| 2019 Q4 | 1/17/2020 | 1,535 | 0.1% | 24,200 | 12/31/2019 |